FoundationOne CDx multigene panel test identified AKT1 E17K, a common mutation in PSP [7], and two TP53 mutations (R280T and E287K) with a low tumor mutation burden (3 muts/Mb). This evidence concerns the gene AKT1 and neoplasm.